Y. Akdag, "Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility.," Pharmaceutical development and technology , vol.28, no.1, pp.124-137, 2023
Akdag, Y. 2023. Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility.. Pharmaceutical development and technology , vol.28, no.1 , 124-137.
Akdag, Y., (2023). Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility.. Pharmaceutical development and technology , vol.28, no.1, 124-137.
Akdag, YAĞMUR. "Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility.," Pharmaceutical development and technology , vol.28, no.1, 124-137, 2023
Akdag, YAĞMUR A. . "Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility.." Pharmaceutical development and technology , vol.28, no.1, pp.124-137, 2023
Akdag, Y. (2023) . "Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility.." Pharmaceutical development and technology , vol.28, no.1, pp.124-137.
@article{article, author={YAĞMUR AKDAĞ ÇAYLI}, title={Nanoparticle-Containing Lyophilized Dry Powder Inhaler Formulations Optimized Using Central Composite Design with Improved Aerodynamic Parameters, and Redispersibility.}, journal={Pharmaceutical development and technology}, year=2023, pages={124-137} }